Heather Loring
Associate Director - Search & Evaluation AstraZeneca
Heather is an Associate Director in Search and Evaluation at AstraZeneca, where she evaluates strategic partnership opportunities to complement and strengthen AstraZeneca’s growing portfolio in respiratory and immunology. Prior to joining AstraZeneca, Heather was an Engagement Manager at Health Advances, a healthcare consulting firm, where she led strategic assessments and commercial due diligence across indications on behalf of pharma and biotech clients. She holds a BS in Biochemistry from Trinity College and a PhD in Biomedical Sciences from University of Massachusetts Medical School.
Seminars
This highly practical workshop is designed for teams looking to understand what separates successful intranasal development programs from those that fail. Through open discussion, attendees will explore how to build robust development strategies that generate confidence among investors, partners, regulators, and future commercial stakeholders.
Discussion Areas:
- What evidence convinces investors to fund intranasal programs to de-risk programs?
- Understanding reimbursement and commercialization requirements and avoiding common development
- Understand how large pharma evaluates emerging intranasal technologies, platforms, and therapeutic programs when considering partnership or licensing opportunities
- Identify the scientific, clinical, and regulatory milestones that increase confidence and help transform promising innovation into a commercially attractive asset
- Learn how developers can reduce perceived development risk, strengthen differentiation, and build evidence packages that support productive conversations with strategic partners
